 | Up a level |
Chang, Xinyue; Liu, Xuelan; Martina, Byron; Zeltins, Andris; Augusto, Gilles; Vogel, Monique; Mohsen, Mona O; Speiser, Daniel E; Bachmann, Martin F (2023). Vaccination using mutated receptor binding domains of SARS-CoV-2: Evidence for partial immune escape but not serotype formation. Frontiers in immunology, 14(1114396), p. 1114396. Frontiers Research Foundation 10.3389/fimmu.2023.1114396
Chang, Xinyue; Liu, Xuelan; Mohsen, Mona O; Zeltins, Andris; Martina, Byron; Vogel, Monique; Bachmann, Martin F (2022). Induction of Broadly Cross-Reactive Antibodies by Displaying Receptor Binding Domains of SARS-CoV-2 on Virus-like Particles. Vaccines, 10(2) MDPI 10.3390/vaccines10020307
Mohsen, Mona O.; Balke, Ina; Zinkhan, Simon; Zeltina, Villija; Liu, Xuelan; Chang, Xinyue; Krenger, Pascal S.; Plattner, Kevin; Gharailoo, Zahra; Vogt, Anne-Cathrine S.; Augusto, Gilles; Zwicker, Marianne; Roongta, Salony; Rothen, Dominik A.; Josi, Romano; J. Da Costa, Joana; Sobczak, Jan M.; Nonic, Aleksandra; Brand, Lee-Anne; Nuss, Katja; ... (2022). A scalable and highly immunogenic virus-like particle-based vaccine against SARS-CoV-2. Allergy, 77(1), pp. 243-257. Wiley 10.1111/all.15080
Vogel, Monique; Augusto, Gilles; Chang, Xinyue; Liu, Xuelan; Speiser, Daniel; Mohsen, Mona O.; Bachmann, Martin F. (2022). Molecular definition of severe acute respiratory syndrome coronavirus 2 receptor-binding domain mutations: Receptor affinity versus neutralization of receptor interaction. Allergy, 77(1), pp. 143-149. Wiley 10.1111/all.15002
Augusto, Gilles; Mohsen, Mona O.; Zinkhan, Simon; Liu, Xuelan; Vogel, Monique; Bachmann, Martin F. (2022). In vitro data suggest that Indian delta variant B.1.617 of SARS-CoV-2 escapes neutralization by both receptor affinity and immune evasion. Allergy, 77(1), pp. 111-117. Wiley 10.1111/all.15065
Chang, Xinyue; Zeltins, Andris; Mohsen, Mona O.; Gharailoo, Zahra; Zha, Lisha; Liu, Xuelan; Walton, Senta; Vogel, Monique; Bachmann, Martin F. (2021). A Novel Double Mosaic Virus-like Particle-Based Vaccine against SARS-CoV-2 Incorporates Both Receptor Binding Motif (RBM) and Fusion Domain. Vaccines, 9(11) MDPI 10.3390/vaccines9111287
Chang, Xinyue; Sousa Augusto, Gilles; Liu, Xuelan; Kündig, Thomas M; Vogel, Monique; Mohsen, Mona O; Bachmann, Martin (2021). BNT162b2 mRNA COVID-19 vaccine induces antibodies of broader cross-reactivity than natural infection, but recognition of mutant viruses is up to 10-fold reduced. Allergy, 76(9), pp. 2895-2998. Wiley 10.1111/all.14893
Chang, Xinyue; Zha, Lisha; Wallimann, Alexandra; Mohsen, Mona O; Krenger, Pascal; Liu, Xuelan; Vogel, Monique; Bachmann, Martin F (2021). Low-affinity but high-avidity interactions may offer an explanation for IgE-mediated allergen cross-reactivity. Allergy, 76(8), pp. 2565-2574. Wiley 10.1111/all.14864
Liu, Xuelan; Chang, Xinyue; Rothen, Dominik; Derveni, Mariliza; Krenger, Pascal; Roongta, Salony; Wright, Edward; Vogel, Monique; Tars, Kaspars; Mohsen, Mona O.; Bachmann, Martin F. (2021). AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate. Vaccines, 9(4) MDPI 10.3390/vaccines9040403
Zha, Lisha; Chang, Xinyue; Zhao, Hongxin; Mohsen, Mona O.; Hong, Liang; Zhou, Yuhang; Chen, Hongquan; Liu, Xuelan; Zhang, Jie; Li, Dong; Wu, Ke; Martina, Byron; Wang, Junfeng; Vogel, Monique; Bachmann, Martin F. (2021). Development of a Vaccine against SARS-CoV-2 Based on the Receptor-Binding Domain Displayed on Virus-Like Particles. Vaccines, 9(4) MDPI 10.3390/vaccines9040395
